List of works by Yung-Jue Bang

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.

scientific article published on 23 June 2017

A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors

scientific article published on 04 June 2019

A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer

scientific article published on 01 February 2003

A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions

scientific article

A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.

scientific article published on 6 June 2017

A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer

scientific article

A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker.

scientific article

A Target-Mediated Drug Disposition Population Pharmacokinetic Model of GC1118, a Novel Anti-EGFR Antibody, in Patients with Solid Tumors

scientific article published on 31 December 2020

A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma

scientific article published on December 2004

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

scientific article

A multi-cohort phase 1 study of ramucirumab plus durvalumab: Preliminary safety and clinical activity in patients with locally advanced and unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma

scientific article published on 01 June 2017

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.

scientific article

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

scientific article

A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells.

scientific article published on October 2003

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer

scientific article published on 12 September 2017

A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumors

scientific article

A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma

scientific article published on September 2010

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

scientific article published on 03 April 2019

A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer

scientific article

A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research

scientific article

A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.

scientific article published in June 2002

A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor

scientific article published on 23 March 2009

A-kinase anchoring protein 12 regulates the completion of cytokinesis

scientific article

AB065. P-36. Debio 1347 in patients with cholangiocarcinoma harboring an FGFR gene alteration: preliminary results

article

ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy

scientific article

AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

scientific article

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

scientific article published on 30 January 2017

Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.

scientific article published on April 2004

Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas.

scientific article published on October 2003

Accomplishments in 2008 in the management of localized gastric cancer

scientific article published on September 2009

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

scientific article published on 04 September 2012

Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification

scientific article

Adenovirus-uteroglobin suppresses COX-2 expression via inhibition of NF-kappaB activity in lung cancer cells

scientific article published on 20 January 2005

Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer

scientific article published on 11 June 2020

Adjuvant and neoadjuvant therapy for gastric cancer

scientific article published on 01 September 2013

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

scientific article

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

scientific article published on 15 October 2014

Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.

scientific article published in April 2012

Adjuvant chemotherapy: an option for Asian patients only?

scientific article published on January 2012

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study

scientific article published on 27 September 2009

Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer

scientific article published on September 2012

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer

scientific article published on 16 June 2016

Age <40Years is an independent prognostic factor predicting inferior overall survival in patients treated with breast conservative therapy

scientific article published on 06 December 2010

Aggressiveness of cancer-care near the end-of-life in Korea

scientific article published on 14 April 2008

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.

scientific article

Analysis of spinal cord proteome in the rats with mechanical allodynia after the spinal nerve injury

scientific article published in December 2003

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

scientific article

Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer

scientific article

Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells

scientific article published on 08 August 2016

Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer

scientific article

Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis

scientific article published on 6 October 2016

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

scientific article published on March 2012

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer

scientific article published on March 2011

Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins

scientific article published on 3 May 2011

Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells

scientific article published on September 2006

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer

scientific article

Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin.

scientific article published on 21 October 2004

Artificial nutrition and hydration in terminal cancer patients: the real and the ideal

scientific article published on 11 November 2006

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial

scientific article published on 13 October 2016

Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.

scientific article published on 11 March 2011

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

scientific article published on 10 September 2020

Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker

scientific article published on 17 September 2013

Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression

scientific article published on March 2002

Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation

scientific article published on 5 February 2004

Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

scientific article

Body mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean data

scientific article

Book Review: Debating Cancer: The Paradox in Cancer Research.

scientific article

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

scientific article published on 18 January 2017

CD24 expression predicts distant metastasis in extrahepatic bile duct cancer

scientific article published on March 2013

CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience

scientific article

CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth

scientific article

Capecitabine for the treatment of gastric cancer

scientific article published on 15 October 2015

Capecitabine in gastric cancer

scientific article

Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway

scientific article

Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions

scientific article published in May 2004

Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target

scientific article published on 10 June 2004

Cell adhesion status-dependent histone acetylation is regulated through intracellular contractility-related signaling activities

scientific article published on 16 June 2005

Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea

scientific article published on 01 June 2019

Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy

scientific article published on 5 May 2017

Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives

scientific article

Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery

article

Chylothorax in Gorham's disease

scientific article

Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation

scientific article published on August 2004

Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors

scientific article published on 22 January 2008

Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.

scientific article published on 13 January 2017

Clinical Implications of VEGF, TGF-β1, and IL-1β in Patients with Advanced Non-small Cell Lung Cancer

scientific article published on 31 December 2013

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma

scientific article published on 16 October 2015

Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung)

scientific article published on 01 December 2012

Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis

scientific article published on 28 November 2019

Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment

scientific article published on 22 September 2011

Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy

scientific article published on 01 April 2011

Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients.

scientific article published on 7 September 2006

Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.

scientific article published on 12 September 2008

Clinicopathologic analysis of ROS1-rearranged non-small-cell lung cancer and proposal of a diagnostic algorithm

scientific article published in November 2013

Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors.

scientific article

Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer

scientific article

Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.

scientific article

Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study

scientific article published on 01 September 2010

Colorectal cancer in Korea: characteristics and trends

scientific article published on 01 July 2002

Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.

scientific article published on December 2010

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

scientific article published on 15 September 2009

Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells

scientific article

Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer

scientific article published on 15 November 2011

Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone

scientific article published in December 2003

Concordance of ATM (ataxia telangiectasia mutated) immunohistochemistry between biopsy or metastatic tumor samples and primary tumors in gastric cancer patients

scientific article published on 15 January 2013

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study

scientific article published on 16 October 2015

Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer

scientific article published in May 2011

Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer

scientific article (publication date: 2012)

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

scientific article

Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells

scientific article published on 03 May 2018

Cyclooxygenase-2 and p53 expressions in endometrial cancer.

scientific article published in September 2004

Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis.

scientific article

Cytotoxic effects of pemetrexed in gastric cancer cells

scientific article published in June 2005

DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

scientific article

DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma

scientific article

DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells

scientific article

DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription

scientific article

DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.

scientific article

Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection

scientific article

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX.

scientific article published on 9 July 2015

Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation

scientific article published on 21 May 2012

Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer

scientific article published on 30 April 2013

Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab.

scientific article published on 15 March 2011

Discrepancies among patients, family members, and physicians in Korea in terms of values regarding the withholding of treatment from patients with terminal malignancies

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis

scientific article

Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer

scientific article published on 10 July 2012

Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.

scientific article

Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial

scientific article published in July 2002

Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor.

scientific article published in August 2005

Does adjuvant radiotherapy suppress liver regeneration after partial hepatectomy?

scientific article published on 27 October 2008

Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer

scientific article published on July 2011

Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells

scientific article

Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage

scientific article published in December 2003

Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-Oncology

scientific article

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer

scientific article published on 26 November 2007

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy

scientific article

Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial

scientific article published on December 2016

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

scientific article

Effect of lapatinib on oral digoxin absorption in patients.

scientific article published on 2 June 2015

Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration

scientific article

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial

scientific article published on 03 September 2020

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

scientific article published on 04 November 2019

Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer.

scientific article published on 27 June 2017

Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting

scientific article

Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer

scientific article published on January 2003

Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer

scientific article published in July 2005

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study

scientific article published on 17 July 2019

Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells

scientific article

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer

scientific article published in January 2005

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.

scientific article

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.

scientific article published on 23 November 2009

Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer

scientific article published on June 2006

Epigenetic-based therapies in cancer: progress to date

scientific article published on December 2011

Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma

scientific article

Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines

scientific article published on 18 October 2013

Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.

scientific article published on 2 February 2011

Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer

scientific article

Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.

scientific article published on 16 September 2013

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives

scientific article published on 22 April 2018

Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in pati

scientific article published on 19 January 2022

Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer

scientific article published on 01 March 2010

Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer

scientific article published in March 2004

Findings of a 1303 Korean whole-exome sequencing study.

scientific article published on 14 July 2017

First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.

scientific article published in July 2006

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811

scientific article published on 10 November 2020

Free-breathing dynamic contrast-enhanced MRI of the abdomen and chest using a radial gradient echo sequence with K-space weighted image contrast (KWIC).

scientific article

GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer

scientific article published on 27 February 2019

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

scientific article published on 25 January 2016

Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells.

scientific article published in January 2003

Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer

scientific article published on 30 June 2008

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

scientific article

Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers

scientific article

Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers

scientific article published on 3 December 2007

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric o

scientific article published on 2 June 2017

HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib

scientific article

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

scientific article

HER2-targeted therapies - a role beyond breast cancer

scientific article published on 23 September 2019

Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study

scientific article published in May 2002

Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody

scientific article (publication date: 2012)

Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma

scientific article published on November 2011

High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer

scientific article published on 01 June 2017

High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.

scientific article

High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy

scientific article published on 30 July 2015

High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer ⬇️

scientific article published on October 9, 2010

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.

scientific article published on 23 August 2012

Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells

scientific article published on December 2006

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

scientific article published on 7 March 2015

Histone deacetylase inhibitors for cancer therapy.

scientific article published on January 2006

Identification and characterization of a novel cancer/testis antigen gene CAGE-1.

scientific article

Identification and characterization of a novel cancer/testis antigen gene CAGE.

scientific article

Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays

scientific article

Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study

scientific article published on 7 December 2011

Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer.

scientific article published in August 2014

Impact of multimodality approach for patients with leptomeningeal metastases from solid tumors

scientific article

Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution

scientific article

In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines ⬇️

scientific article published on July 1, 2003

Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study ⬇️

scientific article published on November 24, 2010

Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer

scientific article

Induction chemotherapy followed by radiotherapy in the treatment of anal cancer

scientific article published in January 2003

Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer

scientific article published on 17 April 2020

Inhibition of Histone Deacetylase 10 Induces Thioredoxin-Interacting Protein and Causes Accumulation of Reactive Oxygen Species in SNU-620 Human Gastric Cancer Cells ⬇️

scientific article published on July 23, 2010

Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding

scientific article published on 27 December 2005

Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase

scientific article published on 13 September 2007

Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer

scientific article published on 01 May 2007

Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein.

scientific article published on 25 March 2009

Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer

scientific article

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival

scientific article published on 25 December 2012

Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?

scientific article published on 23 November 2015

Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?

scientific article published on 4 December 2009

Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer

scientific article published on 01 October 2018

KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer

scientific article published on 01 June 2017

KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer

scientific article published on 19 February 2019

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach

scientific article published on April 2010

KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.

scientific article published on 3 June 2014

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

scientific article published on 20 September 2020

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

scientific article published on 2 March 2011

Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors

scientific article

Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate

scientific article

Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.

scientific article

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study

scientific article

Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.

scientific article

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study

scientific article published on 20 December 2019

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type

scientific article published on 18 August 2005

Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution.

scientific article

Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.

scientific article

Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.

scientific article

MAPK signaling is involved in camptothecin-induced cell death.

scientific article published on December 2002

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib

scientific article published on 31 October 2011

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design

scientific article published on 31 October 2018

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial

scientific article published on 09 July 2020

Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.

scientific article published on 18 November 2015

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients

scientific article

Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications

scientific article published on 22 June 2015

Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications

scientific article published on 23 May 2015

Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity

scientific article published on 3 November 2009

Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer

scientific article published in March 2008

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

scientific article published on 29 October 2012

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

scientific article published on April 2004

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

scientific article

More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity

scientific article published on 4 January 2016

Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment

scientific article

NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations

scientific article published on 8 December 2011

Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer.

scientific article published in November 2007

Neoadjuvant chemotherapy followed by radiotherapy in epidermoid carcinoma of anus

scientific article

Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma

scientific article published in November 2004

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer

scientific article

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy

scientific article published on 30 June 2011

Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy.

scientific article

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells

scientific article published on 10 February 2013

Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article published on 2 November 2017

Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors

scientific article

Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients

scientific article

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer.

scientific article

Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation

scientific article published on 01 April 2006

Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy

scientific article published on October 2016

Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer

scientific article

Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases

scientific article published on 22 October 2012

Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells

scientific article

P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance

scientific article published on 16 March 2010

Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.

scientific article

Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

scientific article

Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells.

scientific article

Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial

scientific article published on 6 December 2016

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

scientific article published on 25 March 2019

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

scientific article published on 3 May 2016

Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012.

scientific article published on 8 February 2018

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

scientific article published on 04 June 2018

Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study.

scientific article

Pertuzumab in gastrointestinal cancer

scientific article

Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function

scientific article

Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer

scientific article published on 13 January 2013

Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

scientific article published on 29 August 2017

Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

scientific article published on 30 December 2019

Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma.

scientific article published on 22 April 2015

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas

scientific article

Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma

scientific article published on 13 March 2020

Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

scientific article published on 20 November 2017

Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer

scientific article

Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors

scientific article

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors

scientific article

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

scientific article published on 15 February 2019

Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies

scientific article

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer

scientific article published on 16 June 2017

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer

scientific article published in January 2002

Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer

scientific article published on 25 June 2015

Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer

scientific article

Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer

scientific article

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

scientific article

Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial

Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme

scientific article

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer

scientific article published on September 2007

Phase II study of sunitinib as second-line treatment for advanced gastric cancer

scientific article

Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.

scientific article published on 18 November 2015

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer

scientific article

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100

scientific article published on 16 November 2020

Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer.

scientific article published in April 2017

Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies.

scientific article published in February 2012

Postoperative chemoradiotherapy in high risk locally advanced gastric cancer

scientific article published on 31 December 2012

Postoperative chemoradiotherapy of pancreatic cancer: what is the appropriate target volume of radiation therapy?

scientific article published on 01 November 2005

Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy

scientific article

Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis

scientific article published on 4 May 2014

Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study

scientific article published on 14 June 2019

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

scientific article published on 14 February 2005

Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy

scientific article published on 07 February 2012

Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome

scientific article published on August 2006

Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy

scientific article published on 09 June 2016

Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy

scientific article published on 23 December 2016

Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer

Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy

scientific article published on 01 February 2010

Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.

scientific article published in June 2010

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

scientific article

Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study ⬇️

scientific article published on September 25, 2010

Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer

scientific article published on 05 May 2016

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer

scientific article published on 31 July 2019

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

scientific article published on 14 October 2015

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

scientific article

Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma

scientific article published on 01 May 2012

Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy

scientific article

Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma

scientific article

Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis

scientific article published on 09 October 2013

Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma

scientific article published in July 2003

Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication

scientific article published on 10 November 2016

Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer.

scientific article published on 2 March 2017

Public awareness of gastric cancer risk factors and disease screening in a high risk region: a population-based study

scientific article published on 30 June 2009

Quality of life in the trastuzumab for gastric cancer trial

scientific article

RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase ⬇️

scientific article published on August 19, 2010

RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib

scientific article

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

scientific article

Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer

scientific article

Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)

scientific article published on 19 August 2020

Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01.

scientific article published on 9 July 2008

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

scientific article published on 17 August 2015

Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer

scientific article published on December 2010

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea

scientific article published on 12 September 2016

Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer

scientific article published on October 2005

Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics

scientific article

Registry of gastric cancer treatment evaluation (REGATE): II treatment practice

scientific article published on 5 August 2013

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial

scientific article published on 20 June 2016

Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer.

scientific article published on 16 April 2012

Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.

scientific article published on 21 February 2017

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

scientific article published on 27 January 2009

Risk stratification and prognostic nomogram for post-recurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma

scientific article

Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.

scientific article published on 23 April 2009

Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience

scientific article published on 01 December 2012

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis

scientific article

S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial

scientific article published on 16 July 2020

S-1-Induced Lacrimal Drainage Obstruction and Its Association with Ingredients/Metabolites of S-1 in Tears and Plasma: A Prospective Multi-institutional Study

scientific article published on 27 February 2017

SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer

scientific article published on 05 February 2019

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study

scientific article published on 10 May 2017

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

scientific article published on 01 November 2019

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

scientific article

Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer

scientific article published on 16 April 2020

Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: the PACT phase Ia/Ib trial

scientific article published on 23 November 2020

Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study

scientific article published on 01 February 2020

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer

scientific article published on 17 December 2015

Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.

scientific article published in July 2004

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

scientific article published on 5 October 2015

Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy

scientific article published on 2 June 2017

Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.

scientific article published in May 2004

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

scientific article published on 21 October 2016

Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.

scientific article

Src as a Therapeutic Target in Biliary Tract Cancer

scientific article published on 22 April 2016

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.

scientific article

Sunitinib in metastatic renal cell carcinoma: an ethnic Asian subpopulation analysis for safety and efficacy

scientific article

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

scientific article

Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer

scientific article published on 20 January 2012

Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer

scientific article

Survival Outcomes and Prognostic Factors of Transcatheter Arterial Chemoembolization for Hepatic Neuroendocrine Metastases

scientific article published on 19 April 2013

Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma

scientific article

Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.

scientific article

Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors

scientific article published on December 2003

T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028

scientific article published on 13 December 2018

TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study.

scientific article published on 10 May 2017

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy

scientific article published on 03 February 2020

TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity

scientific article published on April 2004

TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin

scientific article

TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells

scientific article

Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing

scientific article published on 21 May 2013

The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy

scientific article

The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.

scientific article published on 4 August 2015

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

scientific article

The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer

scientific article

The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis

scientific article

The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.

scientific article

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

scientific article published on 6 September 2008

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen

scientific article published on March 2004

The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy.

scientific article published on 8 December 2013

The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer

scientific article published on 5 December 2013

The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines

scientific article

The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use.

scientific article

The potential for crizotinib in non-small cell lung cancer: a perspective review

scientific article published on November 2011

The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy

scientific article published on 07 November 2019

The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen

scientific article published on 01 April 2012

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer

scientific article published on 11 August 2009

The role of PET/CT in detection of gastric cancer recurrence

scientific article

The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy

scientific article published on 01 January 2010

The signaling network of transforming growth factor beta1, protein kinase Cdelta, and integrin underlies the spreading and invasiveness of gastric carcinoma cells

scientific article

The synergism between Belotecan and cisplatin in gastric cancer

scientific article published on 30 September 2006

Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer

scientific article published on 25 June 2019

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer

scientific article published on 03 December 2018

Therapeutic implication of HER2 in advanced biliary tract cancer

scientific article published on 09 August 2016

Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy--result of chemotherapy in NK/T-cell lymphoma

scientific article published on 01 January 2003

Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center

scientific article

Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells

scientific article

Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells

scientific article (publication date: 19 June 2003)

Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells.

scientific article published on 31 October 2003

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

scientific article published on 29 May 2020

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

scientific article

Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.

scientific article published on January 2008

Treatment of ALK-positive non-small cell lung cancer

scientific article

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy

scientific article

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less

scientific article

Use of olaparib in patients with advanced gastric cancer - Authors' reply

scientific article published in February 2018

Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer

scientific article published on 01 July 2009

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma

scientific article published on 14 July 2015

VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with Sunitinib

scientific article published in September 2011

Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy

scientific article published on 24 September 2009

Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

scientific article published on 8 March 2015

Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression

scientific article

p130 mediates TGF-beta-induced cell-cycle arrest in Rb mutant HT-3 cells

scientific article published in August 2002

Paulina is supported by:

About Paulina

Help